Nissan 7201-1.22%decrease; red down pointing triangle Motor projected an annual net loss of $4.2 billion as it extended its streak of losses, hampered by U.S. tariffs and weaker sales while it forges ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...

The New England Patriots’ season came to an end in disappointing fashion Sunday night when they fell to the Seattle Seahawks in Super Bowl 60. New England’s offense couldn’t get much going, and ...

I exercise most days, but the number on the scale never moves. What’s even the point? Exercise is not very effective for weight loss, but it’s incredibly beneficial for your physical and mental health ...

We’ve come to the end of another season of Fallout, and just like with the first season, there are far more questions. The Fallout Season 2 finale did deliver some answers, though, setting up for an ...

Patients in a phase 2b trial kept losing weight after switching to monthly dosing of Pfizer’s GLP-1 receptor agonist, providing early validation of the drugmaker’s $10 billion bet on Metsera. The ...

Fitbit users could lose access to their devices next month unless they link their profiles to a Google account. The fitness wearable company has set a firm deadline of Feb. 2, 2026, for users to ...

The pace of AI continues to be staggering. From simple pattern recognition systems to large language models (LLMs), and now as we move into the physical AI reality, the power of these systems ...

GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting "GLP-3s," claiming they are taking obesity medications to the next level. GLP-1 (glucagon-like peptide-1) ...

According to research published by the British Medical Journal (BMJ), those using weight-loss injection drugs could also regain weight almost four times faster than they would after dieting once they ...